BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2439086)

  • 1. Synthesis and biological activity of substance P C-terminal hexapeptide analogues: structure-activity studies.
    Janecka A; Koziołkiewicz W; Wasiak T; Cierniewski CS
    Biochem Biophys Res Commun; 1987 Jun; 145(2):942-8. PubMed ID: 2439086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypotensive activity of histidine-containing analogues of C-terminal hexapeptide of substance P.
    Janecka A; Koziołkiewicz W; Wasiak T; Cierniewski CS; Babińska A
    Experientia; 1986 Apr; 42(4):417-8. PubMed ID: 2420636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activity of substance P C-terminal hexapeptide analogues: structure-activity studies.
    Poulos C; Brown JR; Jordan CC
    J Med Chem; 1986 Jul; 29(7):1281-4. PubMed ID: 2433444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and some biological properties of the hexapeptide analog of substance P with a C-terminal thioamide group.
    Kruszyński M; Kupryszewski G; Misterek K; Gumułka S
    Pol J Pharmacol Pharm; 1990; 42(5):483-90. PubMed ID: 1711685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketomethylene pseudopeptide analogues of substance P: synthesis and biological activity.
    Ewenson A; Laufer R; Chorev M; Selinger Z; Gilon C
    J Med Chem; 1986 Feb; 29(2):295-9. PubMed ID: 2419559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dehydro keto methylene and keto methylene analogues of substance P. Synthesis and biological activity.
    Ewenson A; Laufer R; Chorev M; Selinger Z; Gilon C
    J Med Chem; 1988 Feb; 31(2):416-21. PubMed ID: 2448458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activity of analogues of the C-terminal hexapeptide of substance P with modifications at glutaminyl and methioninyl residues. Structure-activity studies.
    Antoniou M; Poulos C; Tsegenidis T
    Int J Pept Protein Res; 1992 Nov; 40(5):395-400. PubMed ID: 1282903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidiuretic activities of substance P and its analogs.
    Ukai M; Nagase T; Hirohashi M; Yanaihara N
    Experientia; 1981 May; 37(5):521-3. PubMed ID: 6166497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialogogic effects on rat submandibular gland of analogs of the C-terminal hexapeptide of substance P.
    Iwabuchi Y; Masuhara T; Sofuku S
    Jpn J Pharmacol; 1992 Mar; 58(3):325-8. PubMed ID: 1381001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of partially modified retro-inverso substance P analogues and their biological activity.
    Chorev M; Rubini E; Gilon C; Wormser U; Selinger Z
    J Med Chem; 1983 Feb; 26(2):129-35. PubMed ID: 6186812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal actions of substance P analogues on cardiovascular responses in the rat: a structure-activity analysis.
    Couture R; Gupta A; Kérouac R; Escher E; Regoli D
    Can J Physiol Pharmacol; 1987 Mar; 65(3):412-8. PubMed ID: 2438022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenic and antigenic properties of the COOH-terminal hexapeptide of substance P.
    Babińska A; Cierniewski CS; Kosiołkiewicz W; Janecka A
    Mol Immunol; 1984 Aug; 21(8):727-30. PubMed ID: 6205258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of antisera obtained to substance P and its C-terminal hexapeptide.
    Babinska A; Cierniewski CS; Koziolkiewicz W; Janecka A
    Int J Pept Protein Res; 1985 Jan; 25(1):69-75. PubMed ID: 2579923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity studies on the C-terminal hexapeptide of substance P with modifications at the glutaminyl and methioninyl residues.
    Poulos C; Stavropoulos G; Brown JR; Jordan CC
    J Med Chem; 1987 Aug; 30(8):1512-5. PubMed ID: 2441056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative activities of substance P-related peptides in the guinea-pig ileum and rat parotid gland, in vitro.
    Gater PR; Jordan CC; Owen DG
    Br J Pharmacol; 1982 Feb; 75(2):341-51. PubMed ID: 6194840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of substance P analogues.
    Haro I; Torres JL; Valencia G; García-Antón JM; Reig F
    Int J Pept Protein Res; 1989 May; 33(5):335-9. PubMed ID: 2475448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance P: structural requirements for the activation of brain catecholamine synthesis and locomotor activity in rats.
    García-Sevilla JA; Magnusson T; Carlsson A; Folkers K
    Arzneimittelforschung; 1983; 33(9):1249-54. PubMed ID: 6196036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance P and analogues: biological activity and degradation.
    Teichberg VI; Blumberg S
    Prog Biochem Pharmacol; 1980; 16():84-94. PubMed ID: 6160595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance P degrading systems of rat parotid and hypothalamus.
    Wormser U; Chorev M; Gilon C; Laufer R; Friedman ZY; Selinger Z
    Biochim Biophys Acta; 1984 Mar; 798(1):28-36. PubMed ID: 6200141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward nonpeptidal substance P mimetic analogues: design, synthesis, and biological activity.
    Chorev M; Roubini E; Gilon C; Selinger Z
    Biopolymers; 1991 May; 31(6):725-33. PubMed ID: 1718472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.